-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for August 2021 in Pharmaceuticals
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for August 2021 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2021. The report portrays detailed comparative data on the number of deals and their value in the last...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for May 2021 in Pharmaceuticals
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for May 2021 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in May 2021. The report portrays detailed comparative data on the number of deals and their value in the last...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for July 2021 in Pharmaceuticals
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for July 2021 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2021. The report portrays detailed comparative data on the number of deals and their value in the last...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for June 2021 in Pharmaceuticals
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for June 2021 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in June 2021. The report portrays detailed comparative data on the number of deals and their value in the last...
-
Track & Monitor
Pharmaceuticals Industry Deals and Trends in February 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
GlobalData's "Pharmaceuticals Industry Deals and Trends in February 2021 - Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in February 2021. The report portrays detailed comparative data on the number of deals and their value...
-
Track & Monitor
Pharmaceuticals Industry Deals and Trends in March 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
GlobalData's "Pharmaceuticals Industry Deals and Trends in March 2021 - Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2021. The report portrays detailed comparative data on the number of deals and their value...
-
Track & Monitor
Pharmaceuticals Industry Deals and Trends in April 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
GlobalData's "Pharmaceuticals Industry Deals and Trends in April 2021 - Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in April 2021. The report portrays detailed comparative data on the number of deals and their value...
-
Sector Analysis
Endometrial Cancer – Global Drug Forecast and Market Analysis to 2030
EC is a uterine malignancy which is often diagnosed in the early stages of the disease due to the common symptom of post-menopausal bleeding. Due to the early diagnosis rate, surgery is the upfront treatment option for patients and only patients with high-risk of relapse are considered for adjuvant therapy with chemotherapy or hormone therapy. The unmet needs associated with EC arise for patients that relapse the upfront therapy since there is a lack of treatments available for advanced and...
-
Track & Monitor
Pharmaceuticals Industry Deals and Trends in January 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
GlobalData's "Pharmaceuticals Industry Deals and Trends in January 2021 - Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in January 2021. The report portrays detailed comparative data on the number of deals and their value...
-
Track & Monitor
Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals – July 2020
GlobalData's “Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals - July 2020” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2020. The report portrays detailed comparative data on the number of deals and their value in the...